Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | CASP1 | P29466 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.44 |
| ▸ | MAT2A | P31153 | 1/20 | 0.44 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28191720 | 0.82 | MAP4K4 (0.47) | KDM4ENPSR1KMT2ACASP1HSD17B10 | |
| SCHEMBL20995827 | 0.80 | MAP4K4 (0.40) | KMT2AMEN1MAP4K4PDE3BPDE3A | |
| SCHEMBL29738160 | 0.80 | MAP4K4 (0.40) | KMT2AMEN1MAP4K4PDE3BPDE3A | |
| SCHEMBL17343157 | 0.80 | GCGR (0.44) | KDM4EKMT2AMAP4K4PDE3BPDE3A | |
| SCHEMBL4443976 | 0.79 | BCHE (0.52) | KDM4ENPSR1KMT2ACASP1MEN1 | |
| SCHEMBL15712766 | 0.79 | ESR1 (0.46) | KDM4ENPSR1KMT2AMEN1MAPT | |
| SCHEMBL17299585 | 0.79 | IDO1 (0.54) | KDM4ENPSR1KMT2ACASP1HSD17B10 | |
| SCHEMBL15124248 | 0.78 | KDM4E (0.45) | KDM4ENPSR1KMT2ACASP1MEN1 | |
| SCHEMBL30576396 | 0.78 | KDM4E (0.45) | KDM4ENPSR1KMT2ACASP1MEN1 | |
| SCHEMBL29398625 | 0.77 | KDM4E (0.66) | KDM4ENPSR1KMT2ACASP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10636982-B2 | Iridium complex and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2020-04-28 | — | — | US | disclosed |
| US-9601704-B2 | Organic light-emitting device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-03-21 | — | — | US | disclosed |
| US-9601704-B2 | Organic light-emitting device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20150372244-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| US-20150372244-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| US-20150364702-A1 | IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150364702-A1 | IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150364703-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150364703-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10636982-B2 | Iridium complex and organic light-emitting device including the same | MAP1LC3C, MAP1LC3B, MAP1LC3A | KDM4E 3661/4885NPSR1 4008/4885KMT2A 1864/4885 |
| US-20150364702-A1 | IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | MAP1LC3C, MAP1LC3B, MAP1LC3A | KDM4E 3661/4885NPSR1 4008/4885KMT2A 1864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.